Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by guerreiroon Oct 06, 2010 7:49pm

296 Views

Post# 17537935

Getting close to the predicted $1

Bids are lining up. This baby is finally ready to soar. Possible additional financing possibly required at above $1. Would like to buy more on pullbacks if it does happen, but I do not see it happing here. We have winner.
This is only my opinion.

<< Previous

Bullboard Posts

Next >>

Three stocks with strong income statements to buy right now